Skip to main content
. 2022 Jan 13;37(1):88–96. doi: 10.1038/s41433-021-01895-2

Table 1.

(a) Demographic and clinical characteristics of patient population (n = 791). (b) Distribution of demographic and clinical characteristics according to final visual acuity (VA).

(a)
Females (n = 232) Male (n = 559)
Age group, n (%)
0–18 130 (56.0) 275 (49.2)
19–50 69 (29.7) 222 (39.7)
>50 33 (14.2) 62 (11.1)
Laterality, n (%)
Right 120 (51.7) 289 (51.7)
Left 112 (48.3) 270 (48.3)
Presenting VA, n (%)
≥6/12 17 (7.3) 25 (4.5)
6/12–6/60 23 (9.9) 45 (8.1)
3/60–1/60 23 (9.9) 48 (8.6)
CF 35 (15.1) 93 (16.6)
HM to LP 123 (53.0) 310 (55.5)
No LP 11 (4.7) 38 (6.8)
Duration from initial injury to surgery (mean ± SD), days 48.92 ± 359.93 50.07 ± 367.14
Duration from presentation to surgery (median, IQR), days 1.0 (1.0–2.0) 1.0 (0.0–2.0)
Number of surgical procedures (mean ± SD), years 1.69 ± 0.82 1.77 ± 0.91
(b)
Variables ≥6/12 (n = 145) 6/12–6/60 (n = 146) 3/60–1/60 (n = 62) CF (n = 109) HM to LP (n = 240) No LP (n = 89) p-value
Age (mean ± SD), years 24.1 ± 15.9 27.1 ± 18.8 29.4 ± 22.8 14.5 ± 18.5 25.6 ± 20.1 21.1 ± 18.4 <0.0011
Age group, n (%)
0–18 69 (47.6) 61 (41.8) 27 (43.5) 80 (73.4) 113 (47.1) 55 (61.8)
19–50 63 (43.4) 65 (44.5) 23 (37.1) 20 (18.3) 95 (39.6) 25 (28.1)
>50 13 (9.0) 20 (13.7) 12 (19.4) 9 (8.3) 32 (13.3) 9 (10.0) <0.0012
Gender, n (%)
Male 99 (68.3) 100 (68.5) 44 (71.0) 72 (66.1) 177 (73.8) 67 (75.3)
Female 46 (31.7) 46 (31.5) 18 (29.0) 37 (33.9) 63 (26.3) 22 (24.7) 0.5682
Laterality, n (%)
OD 72 (49.7) 80 (54.8) 35 (56.5) 53 (48.6) 123 (51.3) 46 (51.7)
OS 73 (50.3) 66 (45.2) 27 (43.5) 56 (51.4) 117 (48.8) 43 (48.3) 0.8772
Presenting VA, n (%)
≥6/12 24 (16.6) 12 (8.2) 2 (3.2) 1 (0.9) 2 (0.8) 1 (1.1)
6/12–6/60 37 (25.5) 25 (17.1) 5 (8.1) 1 (0.9)
3/60–1/60 18 (12.4) 26 (17.8) 16 (25.8) 4 (3.7) 5 (2.1) 2 (2.2)
CF 26 (17.9) 25 (17.1) 3 (4.8) 44 (40.4) 24 (10.0) 6 (6.7)
HM to LP 40 (27.6) 58 (39.7) 36 (58.1) 57 (52.3) 201 (83.8) 41 (46.1)
No LP 2 (1.8) 8 (3.3) 39 (43.8) <0.0013
Shape, n (%)
Triradiate 3 (2.1) 3 (2.1) 5 (8.1) 3 (2.8) 7 (2.9) 6 (6.7)
Irregular 4 (2.8) 2 (1.4) 1 (1.6) 4 (3.7) 9 (3.8) 3 (3.4)
Round 2 (1.4) 3 (2.1) 1 (1.6) 1 (0.9) 1 (0.4) 1 (1.1)
Linear 136 (93.8) 138 (94.5) 55 (88.7) 101 (92.7) 223 (92.9) 79 (88.8) 0.4843
Size (mean ± SD), 4.6 ± 1.8 5.1 ± 2.0 6.0 ± 2.9 5.6 ± 2.1 6.6 ± 3.6 7.4 ± 3.5 <0.0012
Zone, n (%)
1 126 (86.9) 118 (80.8) 48 (77.4) 104 (95.4) 173 (72.1) 57 (64.0)
2 11 (7.6) 22 (15.1) 9 (14.5) 3 (2.8) 33 (13.8) 11 (12.4)
3 8 (5.5) 6 (4.1) 5 (8.1) 2 (1.8) 34 (14.2) 21 (23.6) <0.0012
Structure involvement, n (%)
Sclera 21 (14.5) 20 (13.7) 9 (14.5) 6 (5.5) 31 (12.9) 19 (21.3)
Corneoscleral 21 (14.5) 34 (23.3) 20 (32.3) 21 (19.3) 79 (32.9) 30 (33.7)
Cornea 103 (71.0) 92 (63.0) 33 (53.2) 82 (75.2) 130 (54.2) 40 (44.9) <0.0012
Duration from initial injury to surgery (mean ± SD), days 32.7 ± 203.4 14.8 ± 80.7 101.6 ± 609.2 73.9 ± 429.3 47.7 ± 304.9 74.7 ± 612.0 0.0503
Number of surgical procedures (mean ± SD), years 1.5 ± 0.6 1.8 ± 0.8 1.8 ± 0.7 1.8 ± 0.8 1.9 ± 1.0 1.7 ± 1.0 0.0663
Infections, n (%) 2 (1.4) 4 (2.7) 6 (5.5) 10 (4.2) 10 (11.2) 0.0043
Lid laceration, n (%) 1 (0.7) 4 (2.7) 1 (1.6) 4 (1.7) 3 (3.4) 0.3243

(a) CF counting fingers, HM hand motion, LP light perception.

(b) CF counting fingers, HM hand motion, LP light perception.

1Kruskal–Wallis Test.

2Pearson Chi-Square Test.

3Fisher’s Exact Test.